Mustbio
About:
MustBio utilizes multi-antibody technology to develop immuno-oncology therapeutics.
Website: http://mustbio.com/
Top Investors: Partners Investment, Premier Partners
Description:
MustBio is a biotechnology company that leverages multi-antibody technology to develop therapeutics primarily in the field of immuno-oncology. The company was founded in 2021 and is based in Seoul, South Korea.
Total Funding Amount:
$12.5M
Headquarters Location:
Seoul, Seoul-t'ukpyolsi, South Korea
Founded Date:
2021-01-01
Contact Email:
info(AT)mustbio.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2022-12-08
IPO Status:
Private
Industries:
© 2025 bioDAO.ai